Literature DB >> 30840483

Consumptive coagulopathy is associated with organ dysfunction during PICS.

Leah K Winer1, Nadine Beckmann1, Rosalie A Veile1, Michael D Goodman1,2, Charles C Caldwell1,3, Vanessa Nomellini2,3.   

Abstract

Patients who survive the acute phase of sepsis can progress to persistent inflammation, immunosuppression, and catabolism syndrome (PICS). Although sepsis is characterized by early hypercoagulability and delayed hypocoagulability, coagulopathy during chronic critical illness is not fully understood. The objective of this study was to determine whether sepsis-induced PICS is associated with coagulation abnormalities. Using our previously described murine PICS model, outbred mice underwent cecal ligation and puncture, and coagulability was characterized after 8 days. We found that during PICS the spleen became markedly enlarged with increased splenocytes and splenic megakaryocytes without a concomitant increase in circulating platelets. Microscopy revealed a nearly sevenfold increase in pulmonary microvascular thrombi in PICS mice, along with significantly decreased pulmonary tidal volumes and inspiratory times and with significantly increased respiratory rates. Thromboelastometry showed that PICS mice had significantly delayed clot initiation time but increased clot firmness. Finally, PICS mice displayed delayed thrombin production and decreased overall thrombin concentrations. All together, these data demonstrate a general dysregulation of coagulation resulting in microthrombus formation and compromised lung function. On the basis of these findings, we propose that consumptive coagulopathy constitutes another cardinal feature of PICS and may contribute to the ongoing tissue damage and multiple organ failure that can occur in chronic critical illness.

Entities:  

Keywords:  PICS; coagulopathy; pulmonary microthrombi; sepsis

Mesh:

Year:  2019        PMID: 30840483      PMCID: PMC6589587          DOI: 10.1152/ajplung.00521.2018

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  31 in total

1.  Microparticles impact coagulation after traumatic brain injury.

Authors:  Emily F Midura; Peter L Jernigan; Joshua W Kuethe; Lou Ann Friend; Rosalie Veile; Amy T Makley; Charles C Caldwell; Michael D Goodman
Journal:  J Surg Res       Date:  2015-03-05       Impact factor: 2.192

2.  Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation.

Authors:  Paul B Massion; Pierre Peters; Didier Ledoux; Valentine Zimermann; Jean-Luc Canivet; Pierre P Massion; Pierre Damas; André Gothot
Journal:  Intensive Care Med       Date:  2012-06-27       Impact factor: 17.440

Review 3.  Coagulation and sepsis.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Thromb Res       Date:  2016-11-19       Impact factor: 3.944

Review 4.  Why do patients who have acute lung injury/acute respiratory distress syndrome die from multiple organ dysfunction syndrome? Implications for management.

Authors:  Jean-Louis Vincent; Massimo Zambon
Journal:  Clin Chest Med       Date:  2006-12       Impact factor: 2.878

Review 5.  Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care.

Authors:  Lori F Gentile; Alex G Cuenca; Philip A Efron; Darwin Ang; Azra Bihorac; Bruce A McKinley; Lyle L Moldawer; Frederick A Moore
Journal:  J Trauma Acute Care Surg       Date:  2012-06       Impact factor: 3.313

Review 6.  Neutrophil Activation During Septic Shock.

Authors:  Laure Stiel; Ferhat Meziani; Julie Helms
Journal:  Shock       Date:  2018-04       Impact factor: 3.454

7.  Amitriptyline Treatment Mitigates Sepsis-Induced Tumor Necrosis Factor Expression and Coagulopathy.

Authors:  Brent T Xia; Nadine Beckmann; Leah K Winer; Young Kim; Holly S Goetzman; Rosalie E Veile; Erich Gulbins; Michael D Goodman; Vanessa Nomellini; Charles C Caldwell
Journal:  Shock       Date:  2019-03       Impact factor: 3.454

Review 8.  Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.

Authors:  Hiroyuki Horiguchi; Tyler J Loftus; Russell B Hawkins; Steven L Raymond; Julie A Stortz; McKenzie K Hollen; Brett P Weiss; Elizabeth S Miller; Azra Bihorac; Shawn D Larson; Alicia M Mohr; Scott C Brakenridge; Hironori Tsujimoto; Hideki Ueno; Frederick A Moore; Lyle L Moldawer; Philip A Efron
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

Review 9.  The incredible journey: From megakaryocyte development to platelet formation.

Authors:  Kellie R Machlus; Joseph E Italiano
Journal:  J Cell Biol       Date:  2013-06-10       Impact factor: 10.539

10.  Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569].

Authors:  Gary T Kinasewitz; S Betty Yan; Bruce Basson; Philip Comp; James A Russell; Alain Cariou; Suzane L Um; Barbara Utterback; Pierre-Francois Laterre; Jean-François Dhainaut
Journal:  Crit Care       Date:  2004-02-10       Impact factor: 9.097

View more
  3 in total

1.  The future of sepsis research: time to think differently?

Authors:  Julie A Bastarache
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-08-05       Impact factor: 6.011

2.  Distinct Neutrophil Populations in the Spleen During PICS.

Authors:  Satarupa Sengupta; Charles C Caldwell; Vanessa Nomellini
Journal:  Front Immunol       Date:  2020-05-15       Impact factor: 7.561

Review 3.  General Adaptation in Critical Illness: Glucocorticoid Receptor-alpha Master Regulator of Homeostatic Corrections.

Authors:  Gianfranco Umberto Meduri; George P Chrousos
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-22       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.